Journal of Nuclear Medicine, published on March 15, 2018 as doi:10.2967/jnumed.116.186338 Alpha Emitters for Radiotherapy: Basic Radiochemistry to Clinical Studies _ Part 1 Running title: Alpha Emitters for Radiotherapy Sophie Poty1, Lynn C. Francesconi2,3, Michael R. McDevitt1,4, Michael J. Morris,5 Jason S. Lewis1,6 1Department of Radiology and the Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 2Department of Chemistry, Hunter College, New York, NY, USA 3The Graduate Center of the City University of New York, New York, NY, USA 4Departments of Radiology, Weill Cornell Medical College, New York, NY, USA 5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA 6Departments of Radiology and Pharmacology, Weill Cornell Medical College, New York, NY, USA Correspondence: Jason S. Lewis, PhD, 1275 York Avenue, New York, NY 10065, USA. Phone: 646-888-3038, FAX: 646-422-0408, Email:
[email protected] First author: Sophie Poty, PhD, 1275 York Avenue, New York, NY 10065, USA. Phone: 646- 888-3080, FAX: 646-422-0408, Email:
[email protected] Word count: 5317 Disclaimer: The authors have nothing to disclose. Financial support: The authors gratefully acknowledge the Radiochemistry and Molecular Imaging Probe core, which was supported in part by the NIH/NCI Cancer Center Support Grant P30 CA008748. We gratefully acknowledge Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research and The Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center (JSL) and the fellowship from the François Wallace Monahan Fellowship from the JLM Benevolent Fund (SP).